Cormorant Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,500,000
| Closed | -$41.4M | – | 60 |
|
|
2023
Q2 | $41.4M | Sell |
1,500,000
-200,000
| -12% | -$5.52M | 2.32% | 9 |
|
|
2023
Q1 | $39.1M | Buy |
+1,700,000
| New | +$39.1M | 2.58% | 11 |
|
|
2018
Q3 | – | Sell |
-382,139
| Closed | -$2.57M | – | 62 |
|
|
2018
Q2 | $2.57M | Hold |
382,139
| – | – | 0.19% | 54 |
|
|
2018
Q1 | $3.28M | Sell |
382,139
-17,861
| -4% | -$153K | 0.24% | 42 |
|
|
2017
Q4 | $8.32M | Sell |
400,000
-100,000
| -20% | -$2.08M | 0.87% | 26 |
|
|
2017
Q3 | $8.84M | Hold |
500,000
| – | – | 1.56% | 23 |
|
|
2017
Q2 | $5.66M | Sell |
500,000
-183,600
| -27% | -$2.08M | 0.94% | 28 |
|
|
2017
Q1 | $8.76M | Sell |
683,600
-36,400
| -5% | -$466K | 1.27% | 29 |
|
|
2016
Q4 | $15.8M | Sell |
720,000
-80,000
| -10% | -$1.76M | 2.13% | 15 |
|
|
2016
Q3 | $16.9M | Buy |
+800,000
| New | +$16.9M | 1.86% | 18 |
|